Unmet need: CLL patients intolerant to novel therapies
3 years ago
[{"url":"https://i.ytimg.com/vi/OiFK_44Uu74/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLArgqD5DeP60R2X7qQ7F_y6TeyU0A","width":360,"height":202},{"url":"https://i.ytimg.com/vi/OiFK_44Uu74/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLA3u2022qVIye9jSva_14Qv7ZkNrA","width":720,"height":404}]
[{"text":"Danielle Brander, MD, Duke University School of Medicine, Durham, NC, discusses the treatment of individuals "},{"text":"intolerant","bold":true},{"text":" to novel\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Unmet need: CLL patients intolerant to novel therapies by VJHemOnc \u2013 Video Journal of Hematological Oncology 34 views 3 years ago 2 minutes, 6 seconds","duration":"2 minutes, 6 seconds"}